Skip to main content

An Omics Perspective on Drug Target Discovery Platforms

An omics perspective on drug target discovery platforms

Authors: Paananen J, Fortino V.

Brief Bioinform. 2020 Dec 1;21(6):1937-1953. doi: 10.1093/bib/bbz122.

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Specialties: Genetics